pharmaceutical
HIV-preventing drug to be trialed across England
August 7, 2017Medical Communications, Sales and Marketing NHS, NHS England, PrEP, Truvada, biotech, drugs, pharma, pharmaceutical
NHS England has announced that it will finally make the HIV-preventing drug, PrEP, available to those at risk with the …
Vernalis cough and cold drug knocked-back by FDA
August 7, 2017Sales and Marketing Vernalis, biotech, drugs, pharma, pharmaceutical, tris pharma
Vernalis has been given a second CRL for a cough and cold treatment by the FDA this year. The therapy, …
Jeff Huber, former Google exec, steps down as CEO of GRAIL
August 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GRAIL, Jeff Huber, biotech, drugs, google, pharma, pharmaceutical
Jeff Huber, a former Google executive who spent 14 years at the company, has announced that he will step from …
Bristol-Myers Squibb’s $2.3 billion gamble to boost cancer pipeline
August 4, 2017Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, IFM Therapeutics, biotech, drugs, pharma, pharmaceutical
Bristol-Myers Squibb has agreed a deal to acquire IFM Therapeutics for a potential $2.3 billion. The latter is a biotech …
Chan Zuckerberg Initiative injects $10 million into US big data healthcare project
August 4, 2017Medical Communications, Research and Development Big Data, Chan Zuckerberg initiative, biotech, drugs, healthcare, life sciences, medicine, pharma, pharmaceutical
Facebook CEO Mark Zuckerberg and philanthropist Priscilla Chan have continued their quest to improve worldwide healthcare with the latest donation …
Diabetes drug holds promise to slow Parkinson’s progression
August 4, 2017Medical Communications, Research and Development Parkinson's disease, biotech, diabetes, drugs, pharma, pharmaceutical
There are currently no treatments that are able to slow the development of Parkinson’s disease. This unmet medical need will …
Teva releases financials, shares fall off cliff, plans to axe 7000 jobs
August 3, 2017Medical Communications Teva, biotech, drugs, pharma, pharmaceutical
Teva has released its second quarter financials and they do not make for great reading if you’re an investor. The …
Existing arthritis drug could save thousands in blood cancer treatment
August 3, 2017Research and Development University of Sheffield, arthritis, biotech, blood cancer, drugs, life sciences, medicine, pharma, pharmaceutical
Findings by researchers at the University of Sheffield have indicated that thousands of pounds could be saved in blood cancer …
The common cold cured?
August 3, 2017Research and Development biotech, cold, drugs, pharma, pharmaceutical, rhinovirus
Researchers from Edinburgh Napier University have discovered a crucial step in bringing forward a cure for the common cold. The …
Gene editing carried out, distances ‘designer baby’ possibility
August 3, 2017Research and Development biotech, crispr, drugs, gene editing, pharma, pharmaceutical
The news broke last week that scientists in the US had carried out the first gene editing testing in the …
AstraZeneca’s Priority Review good news provides reprieve
August 2, 2017Sales and Marketing AstraZeneca, FDA, biotech, drugs, pharma, pharmaceutical
If there was a company that needed a series of good news stories this week, it was AstraZeneca. The blow …
Bicycle Therapeutics reveals new CFO
August 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, biotech, drugs, pharma, pharmaceutical
Bicycle Theapeutics, a biotech that is developing its bicyclic peptide product platform, has announced the appointed of Lee Kalowski as …
Record number of drug-related deaths, as opioid crisis hits UK
August 2, 2017Medical Communications, Research and Development biotech, drug deaths, drugs, fentanyl, opioid, pharma, pharmaceutical
Numbers released by the Office for National Statistics (ONC) has revealed that drug misuse deaths were at a record high, …
EMA reveals ‘business continuity plan’ for Brexit, cuts resources from non-essential areas
August 2, 2017Medical Communications, Research and Development EMA, brexit, drugs, life sciences, medicines, pharma, pharmaceutical
The uncertainty caused by Brexit has been and continues to be far-reaching, and perhaps most impactful for business, organisations and …
Daiichi settles undisclosed drug side-effects case for $300 million
August 2, 2017Research and Development, Sales and Marketing Benicar, Daiichi Sankyo, biotech, drugs, pharma, pharmaceutical
Daiichi Sankyo has settled a case alleging that it did not fully disclose adverse side-effects of its drug, Benicar, with …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
